Papers/PMID:25205007
Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: an updated systematic review.
BMC pediatrics2014The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
L-arginine — decreases necrotising enterocolitis incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“L-arginine had a 59% reduction in the incidence of stage II and III NEC (RR 0.41, 95% CI 0.20 to 0.85, NNT = 9) compared with placebo (P = 0.02).”
Quoted verbatim from Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: an updated systematic review.. - Study
- meta-analysis
- Population
- preterm infants born at 34 weeks gestation or less with birth weight 1500 g or less; event definition is stage II and III NEC
Arginine supplementation in prevention of necrotizing enterocolitis in the premature infant: an updated systematic review.2014PMID:25205007Permalink